Metraipolis › archive › dc_4f1f254a2ebd
Anti-Integrin αvβ6 Autoantibodies Predict Response and Treatment Persistence to Advanced Therapies in Ulcerative Colitis — Europe PMC PMID:41642243
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41642243
- DOI
- 10.14309/ctg.0000000000000990
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T11:43:06.879Z
- SHA-256 of the archived text
55e4586a8dedfc2d08a77685055f244469c4263c19de6d09907df791db85bf24- Stable URL of this page
https://metraipolis.com/documento/dc_4f1f254a2ebd
How to cite
Anti-Integrin αvβ6 Autoantibodies Predict Response and Treatment Persistence to Advanced Therapies in Ulcerative Colitis — Europe PMC PMID:41642243 — Europe PMC (en), https://europepmc.org/article/MED/41642243 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f1f254a2ebd (Metraipolis archive dc_4f1f254a2ebd, sha256 55e4586a8dedfc2d08a77685055f244469c4263c19de6d09907df791db85bf24)
BibTeX
@misc{dc4f1f254a2ebd,
title = {Anti-Integrin αvβ6 Autoantibodies Predict Response and Treatment Persistence to Advanced Therapies in Ulcerative Colitis — Europe PMC PMID:41642243},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41642243},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f1f254a2ebd; sha256 55e4586a8dedfc2d08a77685055f244469c4263c19de6d09907df791db85bf24},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41642243. Agents can read the archived copy with the MCP tool read_document.